Enable the development of tailored value propositions and Access, pricing and negotiation strategies for Vaccines and Infectious Disease Assets across Asia Pacific.
Serve as the primary point of contact (POC) for assigned protocols and act as the liaison between Country Operations and the Clinical Trial Team (CTT).
Opportunity to design and execute experiments integrating cellular models of cancer, functional perturbation, and single-cell transcriptomics, to investigate cancer biology, target mechanisms, and therapeutic biomarkers
Opportunity to design, build, validate, and deploy frontier AI/ML and next-generation capabilities for tissue analytics and computational pathology, spanning areas such foundation models, multimodal learning, digital pathology, and emerging AI-enabled biomedical research paradigms.